Investor Profile: AgFunder — Thesis, Cheque Size & How to Apply

AgFunder is one of the best-known venture investors in agrifood technology, and it is also one of the sector's most influential research voices. Based in Silicon Valley, the firm invests in technologies that remove structural constraints to sustainable scale in food, agriculture and human health. It describes its approach as narrowly expansive: focused on agrifood, but open to the artificial intelligence, biotechnology, robotics and climate technologies that converge inside it.

Thesis: backing deeptech that removes limiting factors

AgFunder says progress in food, agriculture and human health lags other sectors, and it backs deeptech and foundational technologies that solve systemic bottlenecks. It is explicit that it is not intimidated by threats to the status quo or conventional wisdom. Artificial intelligence is central to how it works: the firm hired an engineering team long before most venture firms to help identify promising entrepreneurs and technologies, and that team now supports more than its investment team.

Its research arm reinforces the investing. AgFunder publishes the annual AgFunder Global AgriFoodTech Investment Report, and its media platform, AgFunderNews, built a global ecosystem of more than 90,000 subscribers as of 2021.

Fund size and cheque size

AgFunder's overall assets under management were not publicly disclosed in the sources reviewed for this profile, so no total fund size is stated here. One fund is documented in detail: New Carnivore, its alternative protein fund, closed oversubscribed at $21 million in August 2021, surpassing its hard cap, with backing from investors including ADM Ventures and Alexandria Venture Investments. New Carnivore targeted 20 investments overall and had made seven at close. As of 2021, AgFunder managed a portfolio of more than 50 companies across four funds, from offices in Silicon Valley and Singapore.

Notable portfolio companies

AgFunder's current portfolio, as shown on its own website, includes Modern Synthesis, developing natural materials from cellulose; Faeth, which develops clinical-grade foods designed to starve tumours; Eclipse, creating ingredients that enhance wellbeing, starting with human lactoferrin; Aigen, which builds small autonomous weeding robots to minimise chemical use; and Mimetic Medicine, developing non-opioid drug candidates for chronic pain. The New Carnivore portfolio included Nobell Foods, SIMULATE, Alpha Foods, MycoWorks — whose mycelium leather alternative partnered with luxury brand Hermès — Integriculture and Lavva.

Team and programmes

AgFunder was founded in 2013, and its founding partner is Rob Leclerc. Beyond capital, the firm offers founders its research, media and data platform, and an investor network built over more than a decade of publishing sector data. It does not run a cohort accelerator in the style of a classic startup programme; its value-add is sector expertise, data-driven sourcing and a global network of agrifood investors, corporates and founders.

How to apply for funding

AgFunder's website invites startups to challenge the firm, under a "For startups" section, and invites investors to start a conversation through its "Invest with Us" route. No single public application form was identified, so founders should approach through agfunder.com with a pitch that names the limiting factor their technology removes, the evidence behind it, and why it can scale sustainably. Demonstrating real deployment, not just an AI narrative, is what the firm says it looks for.